Lake, J. E., McComsey, G. A., Hulgan, T., Wanke, C. A., Mangili, A., Walmsley, S. L., & Currier, J. S. (2015). Switch to Raltegravir From Protease Inhibitor or Nonnucleoside Reverse-Transcriptase Inhibitor Does not Reduce Visceral Fat In Human Immunodeficiency Virus-Infected Women With Central Adiposity. Open Forum Infect Dis.

Lake, Jordan E., Grace A. McComsey, Todd Hulgan, Christine A. Wanke, Alexandra Mangili, Sharon L. Walmsley, e Judith S. Currier. "Switch to Raltegravir From Protease Inhibitor or Nonnucleoside Reverse-Transcriptase Inhibitor Does Not Reduce Visceral Fat In Human Immunodeficiency Virus-Infected Women With Central Adiposity." Open Forum Infect Dis 2015.

Lake, Jordan E., et al. "Switch to Raltegravir From Protease Inhibitor or Nonnucleoside Reverse-Transcriptase Inhibitor Does Not Reduce Visceral Fat In Human Immunodeficiency Virus-Infected Women With Central Adiposity." Open Forum Infect Dis 2015.